[Artificial intelligence for randomized controlled trials in cardiology: applications and future perspectives] [0.03%]
[心血管病学随机对照试验的人工智能应用及未来展望]
Christian Basile,Alessandro Villaschi,Francesco Orso et al.
Christian Basile et al.
Integrating artificial intelligence (AI) into cardiovascular clinical trials is emerging as a key factor in streamlining patient selection, data collection, endpoint monitoring, and outcome analysis. On the one hand, machine learning and de...
Mattia Petrungaro,Mario Malavasi,Gianfranco Notarianni
Mattia Petrungaro
[2025 ACC/AHA guidelines for the management of acute coronary syndromes: what's new and comparison with the 2023 ESC guidelines] [0.03%]
2025 AHA/ACC急性冠脉综合征管理指南更新要点及与2023 ESC指南对比
Stefano Savonitto,Stefano De Servi
Stefano Savonitto
[Real-world experience with early use of vericiguat in worsening heart failure] [0.03%]
伏葛司曲格列汀治疗恶化的心力衰竭的早期应用经验
Laura Scelsi
Laura Scelsi
Background: Despite guideline-directed medical therapy for heart failure with reduced ejection fraction (HFrEF), a residual risk of adverse outcomes persists, particularly after worsening heart failure (WHF). The VICTORIA...
[Fixed-dose combination therapy with rosuvastatin/acetylsalicylic acid in the cardiovascular risk continuum] [0.03%]
[心血管风险全程管理的rosuvastatin和乙酰水杨酸固定剂量联合治疗]
Stefania Angela Di Fusco,Andrea Matteucci,Antonella Spinelli et al.
Stefania Angela Di Fusco et al.
The use of polypill, a single pill containing more therapeutic agents, has shown to increase therapeutic adherence and improve cardiovascular prognosis. Among the several polypills currently available, the fixed dose combination of rosuvast...
Andrea Matteucci,Stefania Angela Di Fusco,Alessandro Aiello et al.
Andrea Matteucci et al.
Cardiovascular risk stratification represents a cornerstone in preventing and managing atherosclerotic diseases. There has been a profound transformation in risk assessment models in recent years, shifting from static and uniform approaches...
[Cardiac magnetic resonance: prognostic compass in dilated cardiomyopathy] [0.03%]
心脏磁共振在扩张型心肌病预后中的导向作用
Edoardo Menzato,Elisabetta Tonet
Edoardo Menzato
[ANMCO Position paper in collaboration with ITACARE-P: Management of hospital discharge] [0.03%]
[ANMCO与ITACARE-P联合立场文件：医院出院管理]
Carmine Riccio,Francesco Fattirolli,Marco Ambrosetti et al.
Carmine Riccio et al.
Hospital discharge is a crucial moment in the continuity of care, acting as a bridge between the acute phase and the treatment pathway that follows. Far from being a simple administrative act, it is a complex process requiring careful plann...
Practice Guideline
Giornale italiano di cardiologia (2006). 2025 Jul;26(7):519-539. DOI:10.1714/4522.45226 2025